Scholar Rock Holding buy Biotechhunter
Summary
This prediction ended on 31.07.20 with a price of €9.40. Massive losses of -44.71% were the result for the BUY prediction by Biotechhunter. Biotechhunter has 50% into this predictionScholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Scholar Rock Holding | -8.589% | -8.589% | 27.350% | - |
iShares Core DAX® | 1.510% | 2.268% | 18.541% | 18.577% |
iShares Nasdaq 100 | -0.271% | -1.533% | 22.755% | 34.901% |
iShares Nikkei 225® | -0.108% | 0.411% | 10.352% | -0.876% |
iShares S&P 500 | 0.479% | 0.563% | 22.881% | 38.847% |
Comments by Biotechhunter for this prediction
In the thread Scholar Rock Holding diskutieren
In the thread Trading Scholar Rock Holding